Objective: To explore the role of clinical pharmacists in the pharmaceutical care for a neonate with congenital hypeinsulinism and hypoglycemia maintenance therapy. Methods: Clinical pharmacists evaluated the correlation between blood glucose maintenance therapy

drug selection and adverse drug reactions in a child with congenital hyperinsulinemia

and provided suggestions for clinical treatment. Results: After drug therapy

the blood glucose of the neonate was restored to a stable level

and the adverse drug reactions that might be induced by octreotide were treated in a timely manner. After the condition was stabilized

the neonate was transferred to the higher level hospital for the further treatment. Conclusion: Clinical pharmacists should monitor children with congenital hypeinsulinism

formulate drug therapy regimens and put forward drug recommendations

identify adverse drug reactions in a timely manner

and ensure the safety of medication for neonates.